IP Library Granted Patent US 9,969,844
Granted Patent B2
US 9,969,844 · App. 14/801,314 · Granted May 15, 2018

Silicone ligands for quantum dots

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,969,844
App. No.
14/801,314
Granted
May 15, 2018
Kind
B2
Abstract

The present invention relates to silicone polymer ligands for binding to quantum dots. The silicone polymer ligands contain a multiplicity of amine, carboxy, and/or phosphine binding groups suitable for attachment to quantum dots. The present invention also describes a process for the preparation of quantum dot binding ligands.

Claims (87)

1. A quantum dot binding ligand comprising the structure of formula I:

wherein

R 1 , R 2 , R 3 , R 7 , R 8 , and R 9 are each independently C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, -L 3 -(R 11 ) q , cycloalkyl, or aryl;

R 4 and R 5 are each independently C 1-20 -alkyl, C 1-20 heteroalkyl, C 2-20 -alkenyl, C 2-20 -alkynyl, cycloalkyl, or aryl, each optionally substituted with one or more Si(R 12 ) 3 groups;

R 6 is C 1-20 -alkyl, C 1-20 heteroalkyl, C 2-20 -alkenyl, C 2-20 -alkynyl, cycloalkyl, or aryl, each optionally substituted with one or more Si(R 12 ) 3 groups;

each R 11 is independently NR 2a R 2b , C(O)OH, or PR 3a R 3b ;

each of R 2a and R 2b is independently H or C 1-6 alkyl;

each of R 3a and R 3b is independently H or C 1-6 alkyl;

each L 1 is independently C 2-20 alkylene, C 2-20 heteroalkylene, or C 2-8 alkylene-O—C 2-8 alkylene;

each L 2 is independently C 2-20 alkylene, C 2-20 heteroalkylene, C 2-8 alkylene-O—C 2-8 alkylene, C 2-8 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-8 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or C 3-8 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q , wherein each L 2 is substituted with one or more (R 10 ) q , Si(R 12 ) 3 , or C 3-10 cycloalkoxy;

each L 3 is independently C 2-20 alkylene, C 2-20 heteroalkylene, C 2-8 alkylene-O—C 2-8 alkylene, C 2-8 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-8 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or C 3-8 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q ;

each R 10 is independently NR 2a R 2b , C(O)OH, or PR 3a R 3b ;

each R 12 is independently C 1-6 alkyl, cycloalkyl, or aryl;

m is 0 to 1000;

n is 2 to 50; and

q is 1 to 10,

wherein at least one L 2 group is substituted by Si(R 12 ) 3 , and wherein the ligand comprises 2, 3, or 4 different kinds of n repeat units.

2. The quantum dot binding ligand of claim 1 , wherein

R 1 , R 2 , R 3 , R 7 , R 8 , and R 9 are each independently C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, -L 3 -(R 11 ) q , cycloalkyl, or aryl;

R 4 is C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, cycloalkyl, or aryl;

R 5 is C 8-20 alkyl, C 8-20 heteroalkyl, cycloalkyl, or aryl;

R 6 is C 1-20 alkyl, C 1-20 heteroalkyl, C 2-20 alkenyl, C 2-20 alkynyl, cycloalkyl, or aryl;

each L 1 and L 2 is independently C 3-8 alkylene;

each R 10 is independently NR 2a R 2b or C(O)OH;

each of R 2a and R 2b is H or C 1-6 alkyl;

each L 3 is independently C 2-20 alkylene, C 2-20 heteroalkylene, C 2-8 alkylene-O—C 2-8 alkylene, C 2-8 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-8 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or C 3-8 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q ;

m is an integer from 5 to 100;

n is an integer from 2 to 10; and

q is an integer from 1 to 10.

3. The quantum dot binding ligand of claim 1 , wherein L 1 is independently selected from the group consisting of C 3-8 alkylene and C 3-8 alkylene-O—C 2-8 alkylene.

4. The quantum dot binding ligand of claim 1 , wherein each L 1 is independently selected from the group consisting of propylene, butylene, pentylene, or n-propylene-O-isopropylene.

5. The quantum dot binding ligand of claim 1 , wherein at least one L 2 group is substituted by (R 10 ) q .

6. The quantum dot binding ligand of claim 5 , wherein the L 2 -(R 10 ) q is independently selected from the group consisting of C 3-8 alkylene-C(O)OH, C 3-8 alkylene-(C(O)OH) 2 , C 3-8 alkylene-O—C 2-8 alkylene-(C(O)OH) 3 , C 3-8 alkylene-NR 2a R 2b , C 3-8 alkylene-(C(O)NH—C 2-8 alkylene-NR 2a R 2b ) 2 , C 3-8 alkylene-PR 3a R 3b , C 3-8 alkylene-O—C 2-8 alkylene-PR 3a R 3b , and C 3-8 alkylene-(C(O)NH—C 2-8 alkylene-PR 3a R 3b ) 2 .

7. The quantum dot binding ligand of claim 5 , wherein the L 2 -(R 10 ) q is independently selected from the group consisting of C 3-8 alkylene-C(O)OH, C 3-8 alkylene-(C(O)OH) 2 , and C 3-8 alkylene-NR 2a R 2b .

8. The quantum dot binding ligand of claim 5 , wherein the L 2 -(R 10 ) q is independently selected from the group consisting of:

9. The quantum dot binding ligand of claim 1 , wherein the Si(R 12 ) 3 is Si(CH 3 ) 3 .

10. The quantum dot binding ligand of claim 1 , comprising 2 different kinds of n repeat units.

11. The quantum dot binding ligand of claim 1 , wherein at least one L 2 group is substituted by (R 10 ) q and at least one L 2 group is substituted by Si(R 12 ) 3 .

12. The quantum dot binding ligand of claim 1 , wherein

R 1 , R 2 , R 3 , R 7 , R 8 , and R 9 are each independently C 1-3 alkyl;

R 4 and R 5 are each independently C 1-3 alkyl; and

R 6 is C 1-3 alkyl.

13. The quantum dot binding ligand of claim 12 , having the structure of formula II:

14. A method of making a quantum dot binding ligand of claim 1 , which comprises:

reacting:

(a) a thiol functional siloxane polymer of formula IV:

wherein

R 1 , R 2 , R 3 , R 7 , R 8 , and R 9 are each independently C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, -L 3 -(R 11 ) q , cycloalkyl, or aryl;

R 4 and R 5 are each independently C 1-20 -alkyl, C 1-20 heteroalkyl, C 2-20 -alkenyl, C 2-20 -alkynyl, cycloalkyl, or aryl, each optionally substituted with one or more Si(R 12 ) 3 groups;

R 6 is C 1-20 -alkyl, C 1-20 heteroalkyl, C 2-20 -alkenyl, C 2-20 -alkynyl, cycloalkyl, or aryl,

each optionally substituted with one or more Si(R 12 ) 3 groups;

each R 11 is independently NR 2a R 2b , C(O)OH, or PR 3a R 3b ;

each R 12 is independently C 1-6 alkyl, cycloalkyl, or aryl;

L 1 is C 2-20 alkylene, C 2-20 heteroalkylene, or C 2-8 alkylene-O—C 2-8 alkylene;

L 3 is C 2-20 alkylene, C 2-20 heteroalkylene, C 2-8 alkylene-O—C 2-8 alkylene, C 2-8 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-8 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or

C 3-8 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q ;

m is 0 to 1000;

n is 2 to 50; and

q is 1 to 10;

(b) with a first alkene of formula V:

wherein

L 4 is C 2-18 alkylene, C 2-18 heteroalkylene, C 2-6 alkylene-O—C 2-8 alkylene, C 2-6 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-6 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or C 3-6 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q , wherein L 4 is substituted with (R 10 ) q , Si(R 12 ) 3 , or C 3-10 cycloalkoxy;

each R 10 is independently NR 2a R 2b , C(O)OH, or PR 3a R 3b ;

each R 12 is independently C 1-6 alkyl, cycloalkyl, or aryl;

each of R 2a and R 2b is independently H or C 1-6 alkyl;

each of R 3a and R 3b is independently H or C 1-6 alkyl; and

q is 1 to 10;

in the presence of heat, light, or an initiator,

to obtain a compound of formula I.

15. The method of claim 14 , further comprising reacting the mixture of (b) with:

(c) a second alkene of formula V:

wherein

L 4 is C 2-18 alkylene, C 2-18 heteroalkylene, C 2-6 alkylene-O—C 2-8 alkylene, C 2-6 alkylene-(C(O)NH—C 2-8 alkylene) q , C 2-6 heteroalkylene-(C(O)NH—C 2-8 alkylene) q , or C 3-6 alkylene-O—C 1-8 alkylene-(C(O)NH—C 2-8 alkylene) q , wherein L 4 is substituted with (R 10 ) q , Si(R 12 ) 3 , or C 3-10 cycloalkoxy;

each R 10 is independently NR 2a R 2b , C(O)OH, or PR 3a R 3b ;

each R 12 is independently C 1-6 alkyl, cycloalkyl, or aryl;

each of R 2a and R 2b is independently H or C 1-6 alkyl;

each of R 3a and R 3b is independently H or C 1-6 alkyl; and

q is 1 to 10;

in the presence of heat, light, or an initiator,

to obtain a compound of formula I.

16. A composition comprising:

a quantum dot binding ligand of claim 1 ; and

at least one population of light emitting quantum dots.

17. The composition of claim 16 , wherein the quantum dot binding ligand has the structure of formula II:

18. The composition of claim 16 , wherein the light emitting quantum dots are InP.

19. The composition of claim 16 , further comprising a matrix material.

20. The quantum dot binding ligand of claim 1 , comprising 3 different kinds of n repeat units.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE TO BE: 2-1-1, NISHI-SHINJUKU SHINJUKU-KU TOKYO, JAPAN 163-0043 PREVIOUSLY RECORDED AT REEL: 065114 FRAME: 0769. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 9, 2023
From: NANOSYS, INC.
To: SHOEI CHEMICAL INC.
Reel/Frame 065271/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2023
From: NANOSYS, INC.
To: SHOEI CHEMICAL INC.
Reel/Frame 065114/0769 →
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 059569 / FRAME 0840 Recorded Sep 7, 2023
From: FORTRESS CREDIT CORP.,
To: NANOSYS, INC.
Reel/Frame 064836/0263 →
SECURITY INTEREST Recorded Apr 1, 2022
From: NANOSYS, INC.
To: FORTRESS CREDIT CORP., AS AGENT
Reel/Frame 059569/0840 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 49170/0482 Recorded Jul 1, 2021
From: OCEAN II PLO, LLC, AS AGENT
To: NANOSYS, INC.
Reel/Frame 056752/0073 →
SECURITY INTEREST Recorded Jan 17, 2019
From: NANOSYS, INC.
To: OCEAN II PLO, LLC
Reel/Frame 049170/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2016
From: FURUTA, PAUL T.
To: NANOSYS, INC.
Reel/Frame 040693/0366 →